Difference of vascular response between everolimus- and paclitaxel-eluting stents for small coronary artery disease: Optical coherence tomography analysis☆☆☆★

نویسندگان

  • Kenya Nasu
  • Yuji Oikawa
  • Tadanori Aizawa
  • Takahiko Suzuki
چکیده

Background Previous clinical trials have demonstrated the clinical and angiographic superiority of everolimus-eluting stents (EES) compared with paclitaxel-eluting stents (PES) in the small coronary vessel. However, the differences of vascular response including assessment of morphological neointimal tissue (NIT) characteristics using optical coherence tomography (OCT) have not been fully evaluated. The aim of this study is to evaluate the differences of chronic vascular response following small coronary stenting between EES and PES using OCT. Methods and results A prospective OCT examination at 9 month follow-up was performed for 50 small coronary artery diseases (50 patients) treated by a single 2.5 mm stent for each stent group. Cross-sectional area within stent segments were analyzed at an interval of 1 mm. NIT structure (homogeneous or heterogeneous) was evaluated for qualitative assessment. Homogeneous NIT was observed significantly higher and heterogeneous NIT was lower in EES compared with PES (93% vs. 89%; p = 0.003, 6.5% vs. 10.3%; p = 0.002, respectively). The frequencies of exposed and malapposed struts were lower in EES compared with PES (0.2% vs. 1.7%; p = 0.0001, 0.1% vs. 0.3%; p = 0.001, respectively). NIT eccentricity index and NIT area were lower in EES compared with PES (0.69 ± 0.08 vs. 0.76 ± 0.10; p = 0.001, 0.97 ± 0.42 mm2 vs. 1.27 ± 0.67 mm2; p = 0.01, respectively). Conclusions A favorable vascular response was observed after EES implantation compared with PES for small coronary artery disease. In addition, the characteristics of NIT after EES implantation were more stable than PES at 9 month follow-up.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Different patterns of in-stent coverage in drug-eluting stents.

A 65-year-old man had undergone percutaneous revascularization of the left anterior descending artery four years earlier, with two non-overlapping stents being implanted in the same procedure: a first-generation drug-eluting stent (DES) in the proximal segment (2.75 mm×16 mm TAXUS Element paclitaxel-eluting stent) and a second-generation DES in the mid segment (2.5 mm×24 mm PROMUS Element evero...

متن کامل

1-year follow-up optical coherence tomography of a "hybrid" neocarina after T-stenting with small protrusion technique using a bioresorbable vascular scaffold and a metallic stent.

A 75-year-old man with stable angina underwent coronary angiography demonstrating significant stenosis at the bifurcation of the left anterior descending coronary artery (LAD) with a diagonal branch (Figure 1A). Following predilation, a 3.5 28-mm bioresorbable vascular scaffold (BVS) (Absorb, Abbott Vascular, Santa Clara, California) was implanted in the LAD. This was followed by post-dilation ...

متن کامل

Tension gastrothorax mimicking acute coronary syndrome and causing cardiac arrest.

Veldhof S, Rapoza R, Onuma Y, Garcia-Garcia HM, Chevalier B. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary art...

متن کامل

Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.

OBJECTIVES The aim of this study was to investigate the impact of reference vessel diameter (RVD) and lesion length (LL) on the relative safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). BACKGROUND Lesion length and RVD are well-known predictors of adverse events after percutaneous coronary intervention. METHODS Patient-level data were pooled from t...

متن کامل

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)

Percutaneous coronary revascularization has been a mainstay in the management of coronary artery disease since its introduction in the late 1970s. Bare-metal stents and, more recently, first-generation drug-eluting stents (DES), such as sirolimus-eluting (Cypher) and paclitaxel-eluting stents (Taxus), have further improved results of percutaneous coronary intervention (PCI) by improving early r...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 3  شماره 

صفحات  -

تاریخ انتشار 2014